Skip to content

A Single-Center, Prospective, Observational Study on the Dynamic Changes and Clinical Significance of Damage-Associated Molecular Patterns in Peripheral Blood of Patients with Trauma Complicated by Acute Lung Injury

A Single-Center, Prospective, Observational Study on the Dynamic Changes and Clinical Significance of Damage-Associated Molecular Patterns in Peripheral Blood of Patients with Trauma Complicated by Acute Lung Injury

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118071
Enrollment
Unknown
Registered
2026-02-02
Start date
2026-02-09
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with Trauma Complicated by Acute Lung Injury

Interventions

Observation group (Trauma Complicated by Acute Lung Injury):None
Control group:None

Sponsors

Second Affiliated Hospital, University of South China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18 years = 16); 3. Diagnosis and Timing: Diagnosis of Acute Respiratory Distress Syndrome (ARDS) according to the Berlin Criteria within 24-48 hours after admission, which is the target condition of this study—Acute Lung Injury (ALI); 4. Surgical Intervention: Requirement of emergency or elective surgical intervention due to trauma; 5. Informed Consent: Voluntary provision of written informed consent by the patient or their immediate family member after full understanding of the study details.

Exclusion criteria

Exclusion criteria: 1. History of Pre-existing Pulmonary Disease: Presence of significant chronic respiratory conditions such as chronic obstructive pulmonary disease, interstitial lung disease, pulmonary fibrosis, lung cancer, etc. 2. ALI/ARDS Due to Other Causes: ALI/ARDS caused by non-traumatic direct factors such as pneumonia, aspiration, sepsis, pancreatitis, etc. 3. Severe Immune Dysfunction: Known conditions including AIDS, long-term use of high-dose immunosuppressants or glucocorticoids, ongoing chemotherapy, etc. 4. Coexisting Severe Chronic Illnesses: Including end-stage liver disease, renal failure (requiring long-term dialysis), or chronic heart failure classified as New York Heart Association (NYHA) Class III–IV. 5. Limited Life Expectancy: Presence of irreversible severe traumatic brain injury at admission, or an expected survival time of < 72 hours. 6. Inability to Participate in the Study: Pregnant or lactating women, as well as individuals unable to complete the follow-up procedures required by this study for any reason.

Design outcomes

Primary

MeasureTime frame
Severity of Pulmonary Injury;28-day all-cause mortality;

Secondary

MeasureTime frame
The levels of various DAMPs in peripheral blood;APACHE II Score;SOFA Score;Total duration of mechanical ventilation;Length of ICU stay;

Countries

China

Contacts

Public ContactRen Jing

Second Affiliated Hospital, University of South China

jingren@gxmu.edu.cn+86 176 7788 0943

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026